Pelthos Therapeutics, Inc. (PTHS)
26.75
-0.35
(-1.29%)
USD |
NYAM |
May 22, 16:00
26.75
0.00 (0.00%)
After-Hours: 20:00
Pelthos Therapeutics Profit Margin (Quarterly) : -93.87% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -177.9% |
| Cibus, Inc. | -1.26K% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -208.3% |
| Return on Assets | -63.84% |
| Return on Invested Capital | -117.2% |
| Gross Profit Margin (Quarterly) | 70.91% |
| Operating Margin (Quarterly) | -120.0% |
| Return on Net Operating Assets | -77.33% |